KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Income from Continuing Operations (2017 - 2025)

Historic Income from Continuing Operations for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$8.5 million.

  • Bionano Genomics' Income from Continuing Operations rose 8078.24% to -$8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.6 million, marking a year-over-year increase of 7158.19%. This contributed to the annual value of -$112.0 million for FY2024, which is 5181.92% up from last year.
  • Latest data reveals that Bionano Genomics reported Income from Continuing Operations of -$8.5 million as of Q3 2025, which was up 8078.24% from -$6.9 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Income from Continuing Operations registered a high of -$3.1 million during Q1 2025, and its lowest value of -$112.6 million during Q3 2023.
  • For the 5-year period, Bionano Genomics' Income from Continuing Operations averaged around -$29.9 million, with its median value being -$30.0 million (2022).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 25388.1% in 2023, then soared by 9012.79% in 2025.
  • Over the past 5 years, Bionano Genomics' Income from Continuing Operations (Quarter) stood at -$22.9 million in 2021, then tumbled by 68.53% to -$38.7 million in 2022, then dropped by 13.48% to -$43.9 million in 2023, then skyrocketed by 54.15% to -$20.1 million in 2024, then surged by 57.75% to -$8.5 million in 2025.
  • Its Income from Continuing Operations was -$8.5 million in Q3 2025, compared to -$6.9 million in Q2 2025 and -$3.1 million in Q1 2025.